Skip to main content
OpenTrials

Clinical trial condition

Metastatic Solid Tumor

Explore clinical trials studying Metastatic Solid Tumor. Study availability and eligibility vary by location and protocol.

82 public trials 45 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Solid Tumor trial results

Recruiting

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

NCT06465069

Conditions
Adnexal Diseases, Advanced Solid Tumor, Bladder Cancer, +72 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • University of California, San Diego (UCSD) - Moores Cancer Center La Jolla, California, United States
  • UCLA Department of Medicine-Hematology/Oncology Los Angeles, California, United States
  • Sarah Cannon Research Institute at HealthOne Denver, Colorado, United States
View all 38 locations
View Trial Details
Recruiting

Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors

NCT06974110

Conditions
Advanced Solid Tumor, Colonic Diseases, Colorectal Cancer, +31 more
Locations
  • Investigative Site #132 Phoenix, Arizona, United States
  • Investigative Site #101 San Diego, California, United States
  • Investigative Site #128 Tampa, Florida, United States
  • Investigative Site #120 Detroit, Michigan, United States
View all 15 locations
View Trial Details
Recruiting

Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors

NCT06545942

Conditions
Adnexal Diseases, Advanced Solid Tumor, Breast Cancer, +36 more
Locations
  • Investigative Site #108 Goodyear, Arizona, United States
  • Investigative Site #101 La Jolla, California, United States
  • Investigative Site #111 San Francisco, California, United States
  • Investigative Site #104 Lake Mary, Florida, United States
View all 18 locations
View Trial Details
Recruiting

First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors

NCT05875168

Conditions
Advanced Solid Tumor, Metastatic Solid Tumor, Neoplasm Metastasis, +4 more
Locations
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Oregon Health & Science University Portland, Oregon, United States
  • Rhode Island Hospital Providence, Rhode Island, United States
  • University of Texas M.D. Anderson Cancer Center Houston, Texas, United States
View all 33 locations
View Trial Details
Recruiting

A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors

NCT06657144

Conditions
Adenocarcinoma Of Esophagus, Advanced Solid Tumor, Carcinoma, +26 more
Locations
  • The University of Arizona Cancer Center Tucson, Arizona, United States
  • City of Hope Duarte, California, United States
  • University of Colorado - Aurora Cancer Center Aurora, Colorado, United States
  • Winship Cancer Center - Emory University Atlanta, Georgia, United States
View all 30 locations
View Trial Details
Recruiting

A Study of BGB-B455 in Adults With Advanced or Metastatic Solid Tumors

NCT06803680

Conditions
Advanced Solid Tumor, Metastatic Solid Tumor, Neoplasm Metastasis, +4 more
Locations
  • Adventhealth Celebration, Florida, United States
  • Sidney Kimmel Cancer Center Philadelphia, Pennsylvania, United States
  • Avera Cancer Institute Sioux Falls, South Dakota, United States
  • Next Oncology San Antonio, Texas, United States
View all 13 locations
View Trial Details
Recruiting

A Study to Assess the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, Immunogenicity and Antitumour Activity of IPN60300 in Adults With Locally Advanced or Metastatic Solid Tumours

NCT07213817

Conditions
Locally Advanced Solid Tumor, Metastatic Solid Tumor, Neoplasm Metastasis, +4 more
Locations
  • Yale Cancer Center-Yale University New Haven, Connecticut, United States
  • START Midwest Grand Rapids, Michigan, United States
  • Sidney Kimmel Cancer Center Philadelphia, Pennsylvania, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Recruiting

A Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity and Anti-tumour Activity of IPN01203 in Adults With Locally Advanced or Metastatic Solid Tumours Exposed to Immune Checkpoint Inhibitor Therapies

NCT07213830

Conditions
Advanced Solid Tumor, Metastatic Solid Tumor, Neoplasm Metastasis, +4 more
Locations
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • START MidWest PI Sharma Grand Rapids, Michigan, United States
  • Sarah Cannon Research Institute PI McKean Nasville, TN, USA Nashville, Tennessee, United States
  • MD Anderson PI Champiat Houston, Texas, United States
View Trial Details

Related conditions